Compare TLN & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TLN | RDY |
|---|---|---|
| Founded | 2015 | 1984 |
| Country | United States | India |
| Employees | 1880 | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.2B | 11.6B |
| IPO Year | N/A | 2001 |
| Metric | TLN | RDY |
|---|---|---|
| Price | $344.91 | $13.10 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 1 |
| Target Price | ★ $433.50 | $16.90 |
| AVG Volume (30 Days) | 630.3K | ★ 2.1M |
| Earning Date | 05-05-2026 | 05-08-2026 |
| Dividend Yield | N/A | ★ 0.54% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $85.30 | $7.72 |
| Revenue Next Year | $10.97 | $3.50 |
| P/E Ratio | $83.51 | ★ $18.67 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $194.54 | $12.82 |
| 52 Week High | $451.28 | $16.17 |
| Indicator | TLN | RDY |
|---|---|---|
| Relative Strength Index (RSI) | 53.46 | 41.33 |
| Support Level | $305.56 | $12.93 |
| Resistance Level | $345.29 | $14.14 |
| Average True Range (ATR) | 14.89 | 0.25 |
| MACD | 4.83 | 0.00 |
| Stochastic Oscillator | 61.96 | 22.69 |
Talen Energy Corp is an independent power producer and energy infrastructure company based in the United States. It owns and operates several gigawatts of power infrastructure in the United States, including 2.2GW of nuclear power and a dispatchable fossil fleet. The company produces and sells electricity, capacity, and ancillary services into wholesale U.S. power markets, with its generation fleet principally located in the Mid-Atlantic, Ohio, and Montana. Talen's operating segments are: PJM and Others. The PJM segment, which generates maximum revenue, is engaged in electricity generation, marketing activities, and commodity risk and fuel management within the PJM market and is comprised of Susquehanna and Talen's natural gas and coal generation facilities in PJM.
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.